Загрузка...
Ibrutinib inhibits pre-BCR(+) B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK
Targeting B-cell receptor (BCR) signaling is a successful therapeutic strategy in mature B-cell malignancies. Precursor BCR (pre-BCR) signaling, which is critical during normal B lymphopoiesis, also plays an important role in pre-BCR(+) B cell acute lymphoblastic leukemia (B-ALL). Here, we investiga...
Сохранить в:
| Опубликовано в: : | Blood |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5374732/ https://ncbi.nlm.nih.gov/pubmed/28031181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-06-722900 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|